Notice of Proposed Sale · 144
Zimmer Biomet Holdings, Inc.
ZBHNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- ZIMMER BIOMET HOLDINGS, INC.
- Issuer CIK
- 0001136869
- SEC file number
- 001-16407
- Phone
- 5742676131
- Person for whose account securities are to be sold
- Thornal Kevin R
- Relationships to issuer
- Officer
- Street
- 345 EAST MAIN STREET
- City
- WARSAW
- State / country code
- IN
- Postal code
- 46580
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 5,691 | 528,978.45 | 190,737,689 | 09/11/2026 | NYSE | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/01/2026 | Restricted Stock Vesting | Issuer | 5,691 | N | 08/01/2026 | Compensation |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 09/11/2026
- Signed
- /s/ Emily Navaro, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin R. Thornal.
Company context
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
Current securities
Recent company filings
- 4 filingSep 9, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 8, 2026
- 144 filingSep 4, 2026
- SCHEDULE 13G - filed by Capital International Investors regarding ZIMMER BIOMET HOLDINGS, INC.Aug 12, 2026
- Other EventsAug 5, 2026